COMMUNIQUÉS West-GlobeNewswire

Madrigal Pharmaceuticals to Participate in the H.C. Wainwright & Co. 8th Annual MASH Investor Conference

02/10/2024 - 14:00

CONSHOHOCKEN, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced the company will participate in a fireside chat at the H.C. Wainwright 8 th Annual MASH Virtual Investor [...]

CervoMed to Participate in 3rd Annual ROTH Healthcare Opportunities Conference

02/10/2024 - 14:00

Dr. John Alam to Participate in Panel Titled “Opportunities and Challenges When Small Names Go After Blockbuster Indications” BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage [...]

Rudolph E. Tanzi, Co-Director of MassGeneral Institute for Neurodegenerative Disease, Chairs Cognos Neurodegenerative Scientific and Clinical Advisory Board

02/10/2024 - 14:00

INGLEWOOD, California, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Cognos Therapeutics, a private hi-tech medical technology company focused on the development of advanced AI implantable pump SINNAIS for smart delivery of [...]

Glass House Brands to Participate at the Benzinga Cannabis Capital Conference in Chicago on October 8-9, 2024

02/10/2024 - 14:00

LONG BEACH, Calif. and TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (" Glass House " or the " Company ") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest- [...]

Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats

02/10/2024 - 14:00

DURHAM, N.C., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO"), today announced [...]

aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal

02/10/2024 - 14:00

Post hoc analysis of Phase 1b/2a study demonstrated statistically significant difference in time-to-first-relapse for corticosteroid use in therapeutic (3.0 and 5.0 mg/kg efzofitimod) vs subtherapeutic (1.0 mg/kg [...]

Smith+Nephew raises the bar in knee revisions by launching new LEGION™ Hinged Knee System with OXINIUM™ Technology

02/10/2024 - 14:00

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) System is now available in the United States with proprietary OXINIUM (Oxidized Zirconium) implant [...]

Court Ruling: Fluoride Levels Pose Unreasonable Risk to Children’s IQ

02/10/2024 - 13:45

LAKELAND, Fla., Oct. 02, 2024 (GLOBE NEWSWIRE) -- A recent federal court ruling has confirmed the current fluoride levels in U.S. drinking water, endorsed by the Environmental Protection Agency (EPA), pose an [...]

Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®

02/10/2024 - 13:35

- ATH434 shows promise as a disease-modifying therapy for MSA - - ATH434-202 Phase 2 interim data demonstrate stabilization of clinical symptoms and biomarkers in clinical responders - MELBOURNE, Australia and SAN [...]

Cognition Therapeutics Will Participate in the Roth Healthcare Opportunities Conference

02/10/2024 - 13:30

PURCHASE, N.Y., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs to treat neurodegenerative disorders, today [...]

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

02/10/2024 - 13:30

Revolutionary inhaled nitric oxide technology set to reach broader healthcare systems GARDEN CITY, N.Y., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial [...]

Verrica Pharmaceuticals Announces Restructuring of Commercial Organization

02/10/2024 - 13:30

- Company significantly reduces cost structure with a realigned sales, marketing and operational infrastructure - Sales and marketing efforts to focus on pediatricians and expand access beyond dermatologists WEST [...]

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility

02/10/2024 - 13:30

GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an asset-based revolving loan [...]

BioCryst Begins Enrollment in Phase 1 Trial Evaluating BCX17725, a KLK5 Inhibitor, for the Treatment of Netherton Syndrome

02/10/2024 - 13:00

—Potential best-in-class targeted treatment for Netherton syndrome is company’s first protein therapeutic to advance to the clinic— —Initial data from trial expected by end of 2025— RESEARCH TRIANGLE PARK, N.C., Oct. 02 [...]

Blue Point Brewing Hosts 20th Annual Cask Ales Festival

02/10/2024 - 13:00

Sample More Than 150 Unique Firkin-Style Beers at Long Island’s Most Iconic Beer Festival PATCHOGUE, N.Y., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company , Long Island’s original craft brewery and a [...]

BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers

02/10/2024 - 13:00

Strategic head-to-head study of BR-AC vs. standard of care aims to demonstrate healing superiority potential to support increased payor coverage and market growth The study will be conducted in 60 patients at 10 sites [...]

Emergex T Cell-Priming Vaccine Candidate for Betacoronaviruses selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials

02/10/2024 - 13:00

NIAID will be conducting and sponsoring clinical trials to accelerate and to streamline the rapid development of next-generation COVID-19 vaccines ABINGDON, United Kingdom, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergex [...]

Ocugen to Present at the 2024 Cell & Gene Meeting on the Mesa

02/10/2024 - 12:30

MALVERN, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and [...]

Vera Therapeutics Announces Late-Breaking Oral Presentation of ORIGIN Phase 2b Long-term Results at the American Society of Nephrology Kidney Week 2024

02/10/2024 - 12:30

Two informational posters for ORIGIN Phase 3 and ORIGIN Extend trials of atacicept in IgAN accepted for presentation at Kidney Week; In-person and virtual R&D Day to discuss expanded atacicept R&D activities [...]